http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0743065-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351 |
| filingDate | 1996-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afc7bdfcd709c42422cb6b88b05849d6 |
| publicationDate | 1996-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0743065-A2 |
| titleOfInvention | Vanadium compounds for inhibiting bone loss |
| abstract | The present invention provides a method for inhibiting bone loss comprising administering to a human in need of treatment an effective amount of a compound of formula In n wherein n each R is the same or different -H, -C 1 -C 6 alkyl, -CH 2 OH, or -CH 2 O(C 1 -C 6 ) alkyl; and n each R 1 is the same or different -H, -C 1 -C 6 alkyl, -CH 2 OH, or -CH 2 O(C 1 -C 6 )alkyl; nor a pharmaceutically acceptable solvate or hydrate thereof, and pharmaceutical compositions thereof. |
| priorityDate | 1995-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 179.